Intrepid Investment Bankers, a leading middle-market investment bank and the advisory arm of MUFG, a global financial group, announced today that it acted as the exclusive financial advisor to p-value Group, one of the largest independent medical communications agencies in North America, on its sale to Publicis Groupe [Euronext Paris: PUB]. The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close by the end of August 2025.
Leading With Science to Drive Medical Communications
Founded in 2004, p-value Group has established itself as a trusted partner to the world’s leading pharmaceutical and biotech companies. The firm specializes in medical strategy, scientific communications, content development, and speaker bureau management, with a reputation for scientific rigor, client service, and a culture of excellence.
“This is more than an acquisition; it’s a strategic alignment of vision and velocity,” said Linda Corvari, PharmD, Founder and CEO of p-value Group. “Publicis Groupe brings the scale, innovation, and purpose to take our work even further. Together, we’re redefining what’s possible in medical communications.”
An Ideal Fit: Expanding Capabilities
The acquisition strengthens Publicis Groupe’s U.S. medical communications capabilities and supports its broader strategy of integrating science-first solutions across its global network.
“p-value has built a differentiated platform with a strong leadership team and a reputation for excellence in medical communications,” said Adam Abramowitz, Managing Director and Co-Head of Healthcare and Life Sciences at Intrepid. “Given the increasingly complex therapeutic landscape and competitive commercialization environment, this transaction reflects the continued demand for high-quality, science-driven agencies that deliver powerful medical communications capabilities.”
“It was a privilege to work with Linda and her exceptional team. The culture they’ve built at p-value is truly unique, with an unmatched commitment to their clients and each other,” said Jim Freedman, Managing Director and Chairman of Intrepid. “We are proud to have helped find a partner in Publicis Groupe that not only recognizes the value of that culture but is uniquely positioned to preserve it and create meaningful opportunities for the team’s continued growth and success.”
This transaction highlights Intrepid’s deep domain expertise within the pharma services vertical and across marketing agency services.